Guillaume Jovenet

Global Manufacturing Senior Vice President at Grünenthal Group - Worthington, IA, US

Guillaume Jovenet's Colleagues at Grünenthal Group
Gudula Petersen

Governmental Affairs & Patient Engagement Expert

Contact Gudula Petersen

Gabriel Baertschi

Chairman of the Corporate Executive Board and Chief Executive Officer

Contact Gabriel Baertschi

Jan-Uwe Claas

General Manager Country Cluster Europe

Contact Jan-Uwe Claas

Marc Boehme

Sales Director Region West - BU Specialty Products

Contact Marc Boehme

Sascha Reininger

Vice President Global Operations Controlling

Contact Sascha Reininger

Silvia Dickhut

VP, Senior Global Program Lead - Late Stage Development

Contact Silvia Dickhut

Arie Hekelaar

Director Commercial Business Insight Management

Contact Arie Hekelaar

View All Guillaume Jovenet's Colleagues
Guillaume Jovenet's Contact Details
HQ
49-241-569-0
Location
Company
Grünenthal Group
Guillaume Jovenet's Company Details

Grünenthal Group

Worthington, IA, US • 1000 - 4999 Employees
Major Drugs

The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. We are an entrepreneurial specialist delivering true benefits to patients. By sustainably investing in research and development above the industrial average, we are committing to innovation in order to treat unmet medical needs and bring value-adding products to markets. Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients. Altogether, the Grünenthal Group is present in 32 countries with affiliates in Europe, Latin America and the US. Grünenthal products are sold in more than 155 countries and approx. 5,400 employees are working for the Grünenthal Group worldwide. In 2015, Grünenthal achieved revenues of € 1.2 bn. More information: www.grunenthal.com. Search fields for Licensing & Acquisition R&D (from late preclinical to late stage clinical development, focus on small indications, clear differentiation vs. standard of care) Perioperative care Inflammation (niches in rheumatic diseases and other inflammatory diseases) Niche indication and rare diseases Cancer Supportive Care Europe (marketed RX-products for the retail- and or / or hospital business) Pain Perioperative Care Inflammation Neurology/Psychiatry Cancer Supportive Care Bone disorders Movement disorders Latin America (marketed RX-products for the retail- and or / or hospital business) Urology Gynecology Pain Inflammation Neurology/Psychiatry Cancer Supportive Care Grünenthal's Innovative Medicines Unit: www.imu.grunenthal.com Grünenthal's innovative INTAC® technology: www.intac.grunenthal.com Jobs & Career: http://www.grunenthal.com/grt-web/Grunenthal_Group/Jobs-Career/Vacancies/134100187.jsp Imprint: http://grunenthal.com/grt-web/Grunenthal_Group/Service/Imprint/130200018.jsp

Europe: Pain (prescriptive drugs) Further indications Latin America: Pain Central Nervous System Gynecology Further indications R&D: Pain Inflammation
Details about Grünenthal Group
Frequently Asked Questions about Guillaume Jovenet
Guillaume Jovenet currently works for Grünenthal Group.
Guillaume Jovenet's role at Grünenthal Group is Global Manufacturing Senior Vice President.
Guillaume Jovenet's email address is ***@grunenthal.com. To view Guillaume Jovenet's full email address, please signup to ConnectPlex.
Guillaume Jovenet works in the Pharmaceuticals industry.
Guillaume Jovenet's colleagues at Grünenthal Group are Gudula Petersen, Gabriel Baertschi, Jan-Uwe Claas, Marc Boehme, Sascha Reininger, Silvia Dickhut, Arie Hekelaar and others.
Guillaume Jovenet's phone number is 49-241-569-0
See more information about Guillaume Jovenet